Chirayu Amin has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chirayu Amin, on behalf of himself and 33 other promoter group entities and persons acting in concert, has filed a declaration with BSE and NSE confirming that none of them created any encumbrance (pledge, lien, or similar charge) on shares of Alembic Pharmaceuticals during financial year 2024-25. The list includes Alembic Ltd., Shreno Ltd., Nirayu Ltd., Paushak Ltd., and several family members along with trusts and LLPs. This is a routine annual compliance requirement under SEBI's takeover regulations, mandating promoters to disclose if they have encumbered their holdings.
A clean declaration with no encumbrances is mildly positive for shareholders, as it signals that promoter holdings are not pledged and there is no near-term risk of forced selling. However, this is a routine compliance filing and is unlikely to move the stock price meaningfully.